The FDA-Approved Drug Cobicistat Synergizes with Remdesivir To Inhibit SARS-CoV-2 Replication In Vitro and Decreases Viral Titers and Disease Progression in Syrian Hamsters
FDA 批准的药物考比司他与瑞德西韦产生协同作用,在体外抑制 SARS-CoV-2 复制,并降低叙利亚仓鼠的病毒滴度和病情进展
期刊:mBio
影响因子:5.1
doi:10.1128/mbio.03705-21
Iart Luca Shytaj, Mohamed Fares, Lara Gallucci, Bojana Lucic, Mahmoud M Tolba, Liv Zimmermann, Julia M Adler, Na Xing, Judith Bushe, Achim D Gruber, Ina Ambiel, Ahmed Taha Ayoub, Mirko Cortese, Christopher J Neufeldt, Bettina Stolp, Mohamed Hossam Sobhy, Moustafa Fathy, Min Zhao, Vibor Laketa, Ricar
代谢
免疫
微生物学
心血管
新冠
FCM
IF
IHC-P
WB
Human
G3P